Worried about muscle loss on Zepbound® or Ozempic®? Discover the specific protein targets and resistance training protocols required to preserve lean mass while taking GLP-1 medications.

"Food noise" isn’t just a buzzword—it’s a reflection of complex neurobiological signaling. Dr. Joshua Silva, MD, breaks down how GLP-1 medications like semaglutide and tirzepatide interact with the brain's reward centers to quiet persistent cravings and make sustainable weight loss achievable.

Not losing weight on semaglutide or tirzepatide? You’re not alone—and it doesn’t usually mean the medication failed. Learn the most common reasons weight loss can stall, what’s normal, and how to get results back on track with physician-guided care.

What should you eat while taking semaglutide or tirzepatide? This physician-written guide explains the best evidence-based diet for GLP-1 therapy — including protein, fiber, healthy fats, complex carbs, and sustainable habits that support long-term weight loss.

Retatrutide is an investigational weight-loss medication often described as a “GLP-3.” This article explains what it is, how it works, how it compares to semaglutide and tirzepatide, safety considerations, FDA status, and whether patients should wait or start treatment now.

A physician-written guide explaining who should avoid or use caution with GLP-1 and GLP-1/GIP weight-loss medications like semaglutide and tirzepatide.

How fast do GLP-1 medications work? This physician-written guide explains what to expect when starting semaglutide or tirzepatide — including early weight-loss patterns, the dose-escalation delay, and real results from clinical trials. Learn why dose matters and how these medications follow a predictable weight-loss curve over 12–18 months.

Older adults enjoying the benefits of weight loss and eating healthy while using GLP-1 medications (semaglutide or tirzepatide) for safe weight loss, heart health, and muscle and bone support.

Semaglutide and tirzepatide can significantly improve insulin resistance, hormones, and weight in women with PCOS. Learn what clinical research shows—and whether these medications may be right for you.

If you’re comparing Zepbound (tirzepatide, GLP-1/GIP) vs. Wegovy (semaglutide, GLP-1) for weight loss, you’re not alone. These two medications are the most effective weight-loss injections available today — and both can help you lose significant weight safely under physician supervision. This guide breaks down how each medication works, how they differ, which one produces more weight loss, what side effects to expect, and how to choose the option that fits your goals, bud

Do you have to stay on semaglutide or tirzepatide forever to keep the weight off? Not necessarily—but understanding how these GLP-1 and GLP-1/GIP medications work explains why some people benefit from long-term or maintenance therapy. Potere Health MD, serving St George, Cedar City, and Salt Lake City Utah, offers physician-led, evidence-based guidance to help you maintain lasting results safely and confidently.

Excess fat lowers testosterone and raises estrogen. This evidence-based article explains how weight loss can restore balance and what studies show about tirzepatide and TRT, including benefits and side effects.

Zepbound (tirzepatide) is the first FDA-approved medication for obstructive sleep apnea in adults with obesity. Learn how it works and who may benefit.

Medically authored by Joshua Silva, MD | Evidence-Based Weight Loss at Potere Health MD As of 2026, compounded semaglutide and tirzepatide are no longer broadly permitted in the United States. Following resolution of nationwide shortages, the FDA ended its temporary enforcement discretion, meaning these medications may now only be compounded under limited, legally defined circumstances .¹–³ On February 21, 2025 , the U.S. Food and Drug Administration formally declared the

Worried about hair loss while taking Wegovy®, Ozempic® (semaglutide), Zepbound®, or Mounjaro® (tirzepatdie)? Learn why shedding happens during weight loss and how to prevent it.

Learn how the FDA Green List impacts compounded semaglutide and tirzepatide. Understand Import Alert 66-80, patient safety, and what it does not mean.